These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26554380)

  • 1. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
    Bao L; Messer K; Schwab R; Harismendy O; Pu M; Crain B; Yost S; Frazer KA; Rana B; Hasteh F; Wallace A; Parker BA
    PLoS One; 2015; 10(11):e0142487. PubMed ID: 26554380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the genomic heterogeneity of multifocal breast cancer.
    Desmedt C; Fumagalli D; Pietri E; Zoppoli G; Brown D; Nik-Zainal S; Gundem G; Rothé F; Majjaj S; Garuti A; Carminati E; Loi S; Van Brussel T; Boeckx B; Maetens M; Mudie L; Vincent D; Kheddoumi N; Serra L; Massa I; Ballestrero A; Amadori D; Salgado R; de Wind A; Lambrechts D; Piccart M; Larsimont D; Campbell PJ; Sotiriou C
    J Pathol; 2015 Aug; 236(4):457-66. PubMed ID: 25850943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
    Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.
    Karsten M; Stempel M; Radosa J; Patil S; King TA
    Ann Surg Oncol; 2016 Feb; 23(2):471-6. PubMed ID: 26340863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal relatedness in tumour pairs of breast cancer patients.
    Biermann J; Parris TZ; Nemes S; Danielsson A; Engqvist H; Werner Rönnerman E; Forssell-Aronsson E; Kovács A; Karlsson P; Helou K
    Breast Cancer Res; 2018 Aug; 20(1):96. PubMed ID: 30092821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 7. Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
    Roy-Chowdhuri S; de Melo Gagliato D; Routbort MJ; Patel KP; Singh RR; Broaddus R; Lazar AJ; Sahin A; Alvarez RH; Moulder S; Wheler JJ; Janku F; Gonzalez-Angulo AM; Chavez-MacGregor M; Valero V; Ueno NT; Mills G; Mendelsohn J; Yao H; Aldape K; Luthra R; Meric-Bernstam F
    Am J Clin Pathol; 2015 Nov; 144(5):713-21. PubMed ID: 26486734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma.
    Saad RS; Denning KL; Finkelstein SD; Liu Y; Pereira TC; Lin X; Silverman JF
    Mod Pathol; 2008 Oct; 21(10):1200-7. PubMed ID: 18469799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.
    Ostrovnaya I; Olshen AB; Seshan VE; Orlow I; Albertson DG; Begg CB
    Stat Med; 2010 Jul; 29(15):1608-21. PubMed ID: 20205270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
    Girard N; Ostrovnaya I; Lau C; Park B; Ladanyi M; Finley D; Deshpande C; Rusch V; Orlow I; Travis WD; Pao W; Begg CB
    Clin Cancer Res; 2009 Aug; 15(16):5184-90. PubMed ID: 19671847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.
    Bollet MA; Servant N; Neuvial P; Decraene C; Lebigot I; Meyniel JP; De Rycke Y; Savignoni A; Rigaill G; Hupé P; Fourquet A; Sigal-Zafrani B; Barillot E; Thiery JP
    J Natl Cancer Inst; 2008 Jan; 100(1):48-58. PubMed ID: 18159071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative genomic analysis reveals bilateral breast cancers are genetically independent.
    Song F; Li X; Song F; Zhao Y; Li H; Zheng H; Gao Z; Wang J; Zhang W; Chen K
    Oncotarget; 2015 Oct; 6(31):31820-9. PubMed ID: 26378809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacious diagnosis of primary and metastatic human carcinomas with a combination of p53 mutation analysis and clonality analysis of androgen receptor gene.
    Aotake T; Muraoka R; Matsukawa S; Tanigawa N
    Int J Oncol; 1998 Oct; 13(4):773-9. PubMed ID: 9735408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
    Reijnen C; Küsters-Vandevelde HVN; Ligtenberg MJL; Bulten J; Oosterwegel M; Snijders MPLM; Sweegers S; de Hullu JA; Vos MC; van der Wurff AAM; van Altena AM; Eijkelenboom A; Pijnenborg JMA
    Int J Cancer; 2020 Jul; 147(2):478-489. PubMed ID: 32022266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting multifocal breast cancer: a clonality study of ductal carcinoma using whole exome sequencing.
    Schwartz CJ; Dolgalev I; Vasudevaraja V; Kelly S; Heguy A; Snuderl M; Cotzia P; Jour G; Darvishian F
    Hum Pathol; 2019 Dec; 94():71-77. PubMed ID: 31704365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
    Tas F
    Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
    Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H
    Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing of contralateral breast cancer identifies metastatic disease.
    Klevebring D; Lindberg J; Rockberg J; Hilliges C; Hall P; Sandberg M; Czene K
    Breast Cancer Res Treat; 2015 Jun; 151(2):319-24. PubMed ID: 25922084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological criteria and selection algorithms for BRCA1 genetic testing.
    Gadzicki D; Schubert A; Fischer C; Milde S; Lehmann U; Steinemann D; Lück HJ; Kreipe H; Schlegelberger B
    Cancer Genet Cytogenet; 2009 Mar; 189(2):105-11. PubMed ID: 19215791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
    Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
    J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.